Komipharm International Co., Ltd. (KOSDAQ:041960)
South Korea · Delayed Price · Currency is KRW 8,990.00
-70.00 (-0.77%)
At close: Feb 27, 2026
Komipharm International Market Cap
Komipharm International has a market cap or net worth of 650.35 billion as of February 27, 2026. Its market cap has increased by 143.83% in one year.
Market Cap
650.35B
Enterprise Value
665.82B
Revenue
56.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,990.00
Market Cap Chart
Since March 1, 2002, Komipharm International's market cap has increased from 94.26B to 650.35B, an increase of 589.95%. That is a compound annual growth rate of 8.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 650.35B | 28.29% |
| Dec 30, 2025 | 506.94B | 89.57% |
| Dec 30, 2024 | 267.41B | -9.03% |
| Dec 28, 2023 | 293.94B | -34.10% |
| Dec 29, 2022 | 446.06B | -18.67% |
| Dec 30, 2021 | 548.45B | -36.13% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 82.31T |
| Celltrion | 52.20T |
| ALTEOGEN | 21.79T |
| Sam Chun Dang Pharm. | 19.19T |
| Green Cross Holdings | 723.25B |
| Curexo | 698.12B |
| WON TECH | 696.33B |
| i-SENS | 648.76B |